Harbor Custom Development, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224011935 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.575M	$3.575M
YoY Change	-63.02%	-63.02%
Cash & Equivalents	$3.600M
Short-Term Investments
Other Short-Term Assets	$1.251M	$1.251M
YoY Change	-76.48%	-76.48%
Inventory
Prepaid Expenses
Receivables	$279.8K	$279.8K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$5.105M	$5.105M
YoY Change	-69.41%	-69.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.611M	$160.1M
YoY Change	-99.23%	-23.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$597.6K	$597.6K
YoY Change	-88.63%	-88.63%
Total Long-Term Assets	$161.6M	$161.6M
YoY Change	-26.35%	-26.35%
TOTAL ASSETS
Total Short-Term Assets	$5.105M	$5.105M
Total Long-Term Assets	$161.6M	$161.6M
Total Assets	$166.8M	$166.8M
YoY Change	-29.39%	-29.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.548M	$4.548M
YoY Change	-60.36%	-60.36%
Accrued Expenses	$1.333M	$1.333M
YoY Change	-68.77%	-68.77%
Deferred Revenue
YoY Change
Short-Term Debt	$125.3M	$125.3M
YoY Change	8.4%	8.4%
Long-Term Debt Due	$140.3M
YoY Change	6720.28%
Total Short-Term Liabilities	$131.3M	$131.3M
YoY Change	-2.89%	-2.89%
LONG-TERM LIABILITIES
Long-Term Debt	$14.71M	$14.71M
YoY Change	-40.91%	-40.91%
Other Long-Term Liabilities	$12.30M	$12.30M
YoY Change	2138.21%	2138.21%
Total Long-Term Liabilities	$27.00M	$27.00M
YoY Change	6.14%	6.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$131.3M	$131.3M
Total Long-Term Liabilities	$27.00M	$27.00M
Total Liabilities	$158.3M	$158.3M
YoY Change	-1.46%	-1.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$100.6M
YoY Change	313.37%
Common Stock	$43.03M
YoY Change	20.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.478M	$8.478M
YoY Change
Total Liabilities & Shareholders Equity	$166.8M	$166.8M
YoY Change	-29.39%	-29.39%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001784567
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent		usd
CY2023Q4	us-gaap	Notes Payable To Bank NotesPayableToBank		usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability		usd
CY2023Q4	HCDI	Right Of Use Liabilities RightOfUseLiabilities		usd
CY2022Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	HCDI	Bankruptcy Expense BankruptcyExpense		usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022	HCDI	Dissolution Of Noncontrolling Interest DissolutionOfNoncontrollingInterest		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023	HCDI	Stock Issued During Period Value Pre Funded Warrants Exercised StockIssuedDuringPeriodValuePreFundedWarrantsExercised		usd
CY2023	HCDI	Stock Issued During Period Values Reverse Stock Splits StockIssuedDuringPeriodValuesReverseStockSplits		shares
CY2023	HCDI	Impairment Loss On Note Receivable ImpairmentLossOnNoteReceivable		usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset		usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	HCDI	Payments Of Financing Fees Related Party Construction Loans PaymentsOfFinancingFeesRelatedPartyConstructionLoans		usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	HCDI	Proceeds From Issuance Of Pre Funded And Common Warrants ProceedsFromIssuanceOfPreFundedAndCommonWarrants		usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	HCDI	Bankruptcy Items Professional Fees And Employee Compensation Paid BankruptcyItemsProfessionalFeesAndEmployeeCompensationPaid		usd
CY2023	HCDI	Termination Of Right Of Use Leases TerminationOfRightOfUseLeases		usd
CY2022	HCDI	Cancellation Of Debt To Earnest Money CancellationOfDebtToEarnestMoney		usd
CY2023	HCDI	Lease Obligation Converted To Debt LeaseObligationConvertedToDebt		usd
CY2022	HCDI	Termination Of Finance Leases TerminationOfFinanceLeases		usd
CY2023	HCDI	Financing Of Fixed Assets Additions FinancingOfFixedAssetsAdditions		usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2022	HCDI	Exercise Of Pre Funded Warrants ExerciseOfPreFundedWarrants		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023	us-gaap	Dilutive Securities DilutiveSecurities		usd
CY2022	us-gaap	Dilutive Securities DilutiveSecurities		usd
CY2022Q4	us-gaap	Liabilities Subject To Compromise Accounts Payable And Accrued Liabilities LiabilitiesSubjectToCompromiseAccountsPayableAndAccruedLiabilities		usd
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://harborcustomdev.com/20231231#RightOfUseLiabilities
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://harborcustomdev.com/20231231#RightOfUseLiabilities
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization		usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization		usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability		usd
CY2023	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2023Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments		usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards		usd
CY2022Q4	HCDI	Deferred Tax Assets Baddebt Expense DeferredTaxAssetsBaddebtExpense		usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent		usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2022	HCDI	Valuation Allowance ValuationAllowance		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance		pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost		pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate		pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments		pure
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023	HCDI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod		shares
CY2023	HCDI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023Q4	HCDI	Costs And Estimated Earnings In Excess Of Billings On Uncompleted Contracts CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts		usd
CY2022Q4	HCDI	Costs And Estimated Earnings In Excess Of Billings On Uncompleted Contracts CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39266
CY2023	dei	Entity Registrant Name EntityRegistrantName	Harbor Custom Development, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WA
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4827436
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1201 Pacific Avenue, Suite 1200
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Tacoma
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98402
CY2023	dei	City Area Code CityAreaCode	(253)
CY2023	dei	Local Phone Number LocalPhoneNumber	649-0636
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	5000000.0	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2686431	shares
CY2023	dei	Auditor Firm AuditorFirmId	89
CY2023	dei	Auditor Name AuditorName	Rosenberg Rich Baker Berman, P.A
CY2023	dei	Auditor Location AuditorLocation	Somerset, New Jersey
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3574500	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9665300	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	597600	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	597600	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	279800	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1707000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	950000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	4525300	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1250900	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	5318100	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	156738400	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	205478200	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1610500	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2289500	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1749200	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1926100	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4659300	usd
CY2023Q4	us-gaap	Assets Assets	166750900	usd
CY2022Q4	us-gaap	Assets Assets	236166400	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	5945900	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	14090700	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	634700	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	25300	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	497400	usd
CY2023Q4	HCDI	Contract With Customer Liability Deferred Revenue ContractWithCustomerLiabilityDeferredRevenue	49900	usd
CY2022Q4	HCDI	Contract With Customer Liability Deferred Revenue ContractWithCustomerLiabilityDeferredRevenue	52000	usd
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	529300	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	378500	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	600000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	14178700	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	24359700	usd
CY2022Q4	us-gaap	Notes Payable To Bank NotesPayableToBank	2057100	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	154500	usd
CY2022Q4	HCDI	Right Of Use Liabilities RightOfUseLiabilities	2779400	usd
CY2023Q4	HCDI	Liabilities Not Subject To Compromise LiabilitiesNotSubjectToCompromise	146051400	usd
CY2022Q4	HCDI	Liabilities Not Subject To Compromise LiabilitiesNotSubjectToCompromise	160610500	usd
CY2023Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	12221500	usd
CY2023Q4	us-gaap	Liabilities Liabilities	158272900	usd
CY2022Q4	us-gaap	Liabilities Liabilities	160610500	usd
CY2023Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3799799	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3799799	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3799799	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3799799	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	62912100	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	62912100	usd
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2686431	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2686431	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	718835	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	718835	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	43030200	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	35704700	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3096800	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1266300	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100561100	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24327200	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8478000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	75555900	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	166750900	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	236166400	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59256700	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55414300	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	110691900	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	55866800	usd
CY2023	us-gaap	Gross Profit GrossProfit	-51435200	usd
CY2022	us-gaap	Gross Profit GrossProfit	-452500	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	9754200	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	16237700	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-61189400	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-16690200	usd
CY2023	us-gaap	Interest Expense InterestExpense	2602600	usd
CY2022	us-gaap	Interest Expense InterestExpense	1760000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	151000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	465600	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-47700	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3433800	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	51500	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	38000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2447800	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4690200	usd
CY2023	HCDI	Bankruptcy Expense BankruptcyExpense	392500	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-64029700	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21380400	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4589400	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4458200	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-68619100	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-16922200	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-500	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7614800	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7759900	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-76233900	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24681600	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-39.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-35.29
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-39.19
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-35.29
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1945233	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	699490	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1945233	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	699490	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	99737800	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8600	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	515500	usd
CY2022	us-gaap	Dividends Dividends	7759900	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	437700	usd
CY2022	HCDI	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	413800	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-16922200	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	75555900	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	75555900	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	218100	usd
CY2023	us-gaap	Dividends Dividends	7614800	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	602600	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	8335300	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-68619100	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8478000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8478000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-68619100	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-16922200	usd
CY2023	us-gaap	Depreciation Depreciation	333500	usd
CY2022	us-gaap	Depreciation Depreciation	1407400	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	176900	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	542800	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-47700	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-3433800	usd
CY2023	us-gaap	Loss On Contracts LossOnContracts	153400	usd
CY2022	us-gaap	Loss On Contracts LossOnContracts	159100	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	48825700	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	3602600	usd
CY2022	HCDI	Impairment Loss On Note Receivable ImpairmentLossOnNoteReceivable	1200000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	218100	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	515500	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	640300	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	457400	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1427200	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	593500	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-2167200	usd
CY2023	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	-3575300	usd
CY2022	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	3725300	usd
CY2023	HCDI	Increase Decrease In Prepaid Expenses And Other Assets IncreaseDecreaseInPrepaidExpensesAndOtherAssets	-4413300	usd
CY2022	HCDI	Increase Decrease In Prepaid Expenses And Other Assets IncreaseDecreaseInPrepaidExpensesAndOtherAssets	1499900	usd
CY2023	HCDI	Increase Decrease On Real Estate IncreaseDecreaseOnRealEstate	-2937900	usd
CY2022	HCDI	Increase Decrease On Real Estate IncreaseDecreaseOnRealEstate	84637700	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-4659300	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	4010300	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6093000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3428100	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-625500	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	338300	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2100	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7200	usd
CY2023	HCDI	Increase Decrease Right Of Use Liability IncreaseDecreaseRightOfUseLiability	-224600	usd
CY2022	HCDI	Increase Decrease Right Of Use Liability IncreaseDecreaseRightOfUseLiability	255800	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8155700	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-93873700	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2646400	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	218100	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5113300	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	218100	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2466900	usd
CY2023	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	65836600	usd
CY2022	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	89559300	usd
CY2023	us-gaap	Repayments Of Construction Loans Payable RepaymentsOfConstructionLoansPayable	48578300	usd
CY2022	us-gaap	Repayments Of Construction Loans Payable RepaymentsOfConstructionLoansPayable	17115900	usd
CY2023	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	1864000	usd
CY2022	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	2470200	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-8177300	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	8669900	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	75000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	14071800	usd
CY2022	HCDI	Payments Of Financing Fees Related Party Construction Loans PaymentsOfFinancingFeesRelatedPartyConstructionLoans	105400	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	25000000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10821300	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1097700	usd
CY2023	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	645300	usd
CY2022	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	1115500	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2057100	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3894200	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	74800	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	104100	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	634700	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	7796100	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	437700	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	602600	usd
CY2023	HCDI	Proceeds From Issuance Of Pre Funded And Common Warrants ProceedsFromIssuanceOfPreFundedAndCommonWarrants	8335400	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8600	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	413700	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1846800	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	75442900	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6090800	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15963900	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10262900	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26226800	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4172100	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10262900	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	14760300	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	8635600	usd
CY2023	HCDI	Bankruptcy Items Professional Fees And Employee Compensation Paid BankruptcyItemsProfessionalFeesAndEmployeeCompensationPaid	261000	usd
CY2022	HCDI	Termination Of Right Of Use Leases TerminationOfRightOfUseLeases	346900	usd
CY2023	HCDI	Amortization Of Debt Discount Capitalised AmortizationOfDebtDiscountCapitalised	3023800	usd
CY2022	HCDI	Amortization Of Debt Discount Capitalised AmortizationOfDebtDiscountCapitalised	2307000	usd
CY2023	HCDI	Promissory Notes Issued For Earnest Money PromissoryNotesIssuedForEarnestMoney	300000	usd
CY2022	HCDI	Promissory Notes Issued For Earnest Money PromissoryNotesIssuedForEarnestMoney	450000	usd
CY2023	HCDI	Cancellation Of Debt To Earnest Money CancellationOfDebtToEarnestMoney	750000	usd
CY2023	HCDI	Financing Of Insurance FinancingOfInsurance	796200	usd
CY2022	HCDI	Financing Of Insurance FinancingOfInsurance	590100	usd
CY2022	HCDI	Lease Obligation Converted To Debt LeaseObligationConvertedToDebt	394800	usd
CY2023	HCDI	Termination Of Finance Leases TerminationOfFinanceLeases	79700	usd
CY2022	HCDI	Financing Of Fixed Assets Additions FinancingOfFixedAssetsAdditions	110000	usd
CY2023	HCDI	Dividends Declared But Not Paid DividendsDeclaredButNotPaid	7614800	usd
CY2022	HCDI	Dividends Declared But Not Paid DividendsDeclaredButNotPaid	634600	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	3595400	usd
CY2023	HCDI	Exercise Of Pre Funded Warrants ExerciseOfPreFundedWarrants	6723000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zEQy78rMKHYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_z9gDuwL9H7b7">Reclassification</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zsgwZXAKwQF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zhVcI6GGrj4j">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing these financial statements in accordance with GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Profit Loss ProfitLoss	-68600000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8200000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3600000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	140300000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0430	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0173	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0354	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	3.73
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y4M17D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4350	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.4234	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.4813	pure
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20 reverse stock split
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-76233900	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24681600	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-76233900	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24681600	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1945233	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	699490	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1945233	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	699490	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-39.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-35.29
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-39.19
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-35.29
CY2023	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.05	pure
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	0.2778	pure
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55414300	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59256700	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55414300	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1200000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59256700	usd
CY2023	us-gaap	Lease Income LeaseIncome	3500000	usd
CY2022	us-gaap	Lease Income LeaseIncome	200000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	300000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	400000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2600000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	8100000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1000000.0	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	4500000	usd
CY2023	HCDI	Financing Receivable Annual Interest Rate FinancingReceivableAnnualInterestRate	0.09	pure
CY2023	us-gaap	Interest Income Other InterestIncomeOther	200000	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	500000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	200000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	200000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	950000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	4525300	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2203200	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2751100	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	592700	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	461600	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1610500	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2289500	usd
CY2023	us-gaap	Depreciation Depreciation	300000	usd
CY2022	us-gaap	Depreciation Depreciation	1400000	usd
CY2023Q4	us-gaap	Land Available For Development LandAvailableForDevelopment	31410100	usd
CY2022Q4	us-gaap	Land Available For Development LandAvailableForDevelopment	47166700	usd
CY2023Q4	us-gaap	Development In Process DevelopmentInProcess	96205900	usd
CY2022Q4	us-gaap	Development In Process DevelopmentInProcess	123927300	usd
CY2023Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	29122400	usd
CY2022Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	34384200	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	156738400	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	205478200	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	6599600	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	11472100	usd
CY2023Q4	HCDI	Retainage Payable RetainagePayable	65500	usd
CY2022Q4	HCDI	Retainage Payable RetainagePayable	1130300	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	143200	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	384700	usd
CY2023Q4	HCDI	Accrued Quarry Reclamation Costs AccruedQuarryReclamationCosts	10000	usd
CY2022Q4	HCDI	Accrued Quarry Reclamation Costs AccruedQuarryReclamationCosts	76200	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	1179500	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	1027400	usd
CY2023Q4	us-gaap	Liabilities Subject To Compromise Accounts Payable And Accrued Liabilities LiabilitiesSubjectToCompromiseAccountsPayableAndAccruedLiabilities	2051900	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	5945900	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	14090700	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	600000	usd
CY2023Q4	us-gaap	General Insurance Expense GeneralInsuranceExpense	500000	usd
CY2023Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	100000	usd
CY2023Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10M
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0895	pure
CY2023Q4	us-gaap	Notes Payable NotesPayable	300000	usd
CY2023Q4	us-gaap	Liabilities Subject To Compromise Accounts Payable And Accrued Liabilities LiabilitiesSubjectToCompromiseAccountsPayableAndAccruedLiabilities	2051900	usd
CY2023Q4	HCDI	Liabilities Subject To Compromise Dividends Payable LiabilitiesSubjectToCompromiseDividendsPayable	7614800	usd
CY2023Q4	HCDI	Liabilities Subject To Compromise Right Of Use Liabilities LiabilitiesSubjectToCompromiseRightOfUseLiabilities	2554800	usd
CY2023Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	12221500	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	8900	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	76000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	17700	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	286800	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	677400	usd
CY2023	us-gaap	Lease Cost LeaseCost	297700	usd
CY2022	us-gaap	Lease Cost LeaseCost	771100	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1749200	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1926100	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2554800	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2779400	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	178800	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	79100	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	99700	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	154500	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	224600	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	358100	usd
CY2022	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	613900	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	74800	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	104100	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	110000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y3M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y2M12D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	316300	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	325700	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	335400	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	345500	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	355800	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1365900	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3044600	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	489800	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2554800	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	6790800	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	1905900	usd
CY2023Q4	HCDI	Deferred Tax Assets Uniform Capitalization DeferredTaxAssetsUniformCapitalization	783700	usd
CY2022Q4	HCDI	Deferred Tax Assets Uniform Capitalization DeferredTaxAssetsUniformCapitalization	1865900	usd
CY2023Q4	HCDI	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	561400	usd
CY2022Q4	HCDI	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	586300	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7400	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	15400	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	200	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	10388700	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	1046700	usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	823100	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	273100	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	72000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	72000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	2000	usd
CY2023Q4	HCDI	Deferred Tax Assets Baddebt Expense DeferredTaxAssetsBaddebtExpense	263700	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	11000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19703800	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5765500	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	290200	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	480200	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	538000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	553800	usd
CY2023Q4	HCDI	Deferred Tax Liabilities Change In Accounting Method DeferredTaxLiabilitiesChangeInAccountingMethod	37600	usd
CY2022Q4	HCDI	Deferred Tax Liabilities Change In Accounting Method DeferredTaxLiabilitiesChangeInAccountingMethod	72200	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	865800	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1106200	usd
CY2023Q4	HCDI	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	18838000	usd
CY2022Q4	HCDI	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	4659300	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18838000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4659300	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	15800000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	30900000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	13000000.0	usd
CY2023Q4	HCDI	Operating Loss Carryforwards Utilized OperatingLossCarryforwardsUtilized	0	usd
CY2022Q4	HCDI	Operating Loss Carryforwards Utilized OperatingLossCarryforwardsUtilized	0	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-107500	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-456300	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	28700	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8400	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	-78800	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	-447900	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-13335700	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3989100	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-834100	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-21200	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-14169800	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-4010300	usd
CY2023	HCDI	Valuation Allowance ValuationAllowance	18838000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4589400	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4458200	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.294	pure
CY2023	HCDI	Effective Income Tax Rate Reconciliation Accrual To Return Changes And Other Adjustments To Deferred Balances Percent EffectiveIncomeTaxRateReconciliationAccrualToReturnChangesAndOtherAdjustmentsToDeferredBalancesPercent	-0.001	pure
CY2022	HCDI	Effective Income Tax Rate Reconciliation Accrual To Return Changes And Other Adjustments To Deferred Balances Percent EffectiveIncomeTaxRateReconciliationAccrualToReturnChangesAndOtherAdjustmentsToDeferredBalancesPercent	-0.005	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.003	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.001	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.012	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.001	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.072	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.209	pure
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	200000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2686431	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2686431	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	718835	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	718835	shares
CY2023	HCDI	Common Stock Voting Right Votes Per Share CommonStockVotingRightVotesPerShare	1	integer
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	7600000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	600000	usd
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-3 and 1-for-25
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	Reverse Stock Split at a ratio of 1-for-20
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23163	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	56.43
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	17186	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	55.47
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	19600	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	23.79
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1081	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	4135	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	34.48
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	37546	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	41.51
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	19696	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	55.55
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	140000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.73
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	79087	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	8.97
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	98459	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.93
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	17543	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	54.67
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	3.73
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	130.00
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	98459	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P9Y
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	13.93
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	17543	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	54.67
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	18486859	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.46
CY2021Q4	HCDI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber	18486859	shares
CY2021Q4	HCDI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	3.46
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	100000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.00
CY2022	HCDI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod	-139295	shares
CY2022	HCDI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedGrantDateFairValue	2.97
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	18447564	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.47
CY2022Q4	HCDI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber	18380897	shares
CY2022Q4	HCDI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	3.47
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	18447564	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.47
CY2023Q4	HCDI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber	18414231	shares
CY2023Q4	HCDI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	3.47
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	5	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59256700	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55414300	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	110691900	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	55866800	usd
CY2023	us-gaap	Gross Profit GrossProfit	-51435200	usd
CY2022	us-gaap	Gross Profit GrossProfit	-452500	usd
CY2023Q4	us-gaap	Assets Assets	166750900	usd
CY2022Q4	us-gaap	Assets Assets	236166400	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	20525800	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	19429800	usd
CY2023Q4	HCDI	Estimated Earnings Loss On Uncompleted Contracts EstimatedEarningsLossOnUncompletedContracts	3702800	usd
CY2022Q4	HCDI	Estimated Earnings Loss On Uncompleted Contracts EstimatedEarningsLossOnUncompletedContracts	3495100	usd
CY2023Q4	HCDI	Costs And Estimated Earnings On Uncompleted Contracts CostsAndEstimatedEarningsOnUncompletedContracts	16823000	usd
CY2022Q4	HCDI	Costs And Estimated Earnings On Uncompleted Contracts CostsAndEstimatedEarningsOnUncompletedContracts	15934700	usd
CY2023Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	16842700	usd
CY2022Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	16273000	usd
CY2023Q4	HCDI	Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts	19700	usd
CY2022Q4	HCDI	Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts	338300	usd
CY2023Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	5600	usd
CY2022Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	159100	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	25300	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	497400	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	30000.00	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	500000	usd
CY2023	HCDI	Uncollected Billings UncollectedBillings	20000.00	usd
CY2022	HCDI	Uncollected Billings UncollectedBillings	1700000	usd

Files In Submission

Name	View Source	Status
0001493152-24-011935-index-headers.html	Edgar Link	pending
0001493152-24-011935-index.html	Edgar Link	pending
0001493152-24-011935.txt	Edgar Link	pending
0001493152-24-011935-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
hcdi-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
hcdi-20231231_cal.xml	Edgar Link	unprocessable
hcdi-20231231_def.xml	Edgar Link	unprocessable
hcdi-20231231_lab.xml	Edgar Link	unprocessable
hcdi-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Harbor Custom Development, Inc.

2024 Q1 Form 10-K Financial Statement

#000149315224011935 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission